MADISON, Wis. & SEATTLE--(BUSINESS WIRE)--April 5, 2006--OpGen Technologies, Inc., the leader in single molecule DNA analysis technology, announced today it entered into agreements with Stratos Product Development, LLC and Micronics, Inc. for the development of its first commercial product. The companies each bring unique capabilities to the innovation of cost-effective, high-throughput instruments and disposables employing OpGen’s Optical Mapping technology platform. The company intends to market these systems worldwide to genome analysis and clinical microbiology research laboratories. Financial terms of the agreements were not disclosed.
